Good Samaritan Hospital Awarded Brain Tumor Certification from The Joint Commission
September 24, 2018
September 24, 2018
TriHealth’s Good Samaritan Hospital announced today that is the first hospital in the Midwest and the third in the country to earn The Joint Commission’s Gold Seal of Approval® for Brain Tumor Certification. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.
"On behalf of the physicians and care providers at TriHealth, we are proud to receive the Joint Commission's Gold Seal of Approval for Brain Tumor Certification and appreciate its demonstration of our commitment to achieve the highest standards of brain tumor care," said Richard Curry, M.D. Director of Neurology, TriHealth Physician Partners. "We used the Joint Commission's rigorous on-site evaluation process as an opportunity to measure how we were going through our own care process, making sure what we were doing with our metrics and tracking measures was the right way to provide our patients exceptional care."
Joint Commission Certification provides an opportunity for staff to develop their skills and knowledge. Achieving certification provides the clinical team with common goals and a concrete validation of their combined efforts.
Good Samaritan Hospital underwent a rigorous on-site review. Joint Commission experts evaluated compliance with national disease-specific care standards as well as with brain tumor-specific requirements. Clinical practice guidelines and performance measures also were assessed.
Established in 2002 and awarded for a two-year period, The Joint Commission’s Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses three core areas:
- Compliance with consensus-based national standards;
- Effective use of evidence-based clinical practice guidelines to manage and optimize care; and
- An organized approach to performance measurement and improvement activities.
"Good Samaritan Hospital has thoroughly demonstrated a high level of care for patients with brain tumors,” said Patrick Phelan, executive director, Hospital Business Development, The Joint Commission. “We commend TriHealth and Good Samaritan Hospital for becoming a leader in brain tumor care, potentially providing a higher standard of service for brain tumor patients in its community.”
Last Updated: September 24, 2018